Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study

Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, Claudio Brunstein, Hailin Wang, Erica D. Warlick, Sergio Giralt, Taiga Nishihori, Rodrigo Martino, Jakob Passweg, Ajoy Dias, Edward Copelan, Gregory Hale, Robert Peter Gale, Melhem Solh, Mohamed A. Kharfan-Dabaja, Miguel Angel Diaz, Siddhartha Ganguly, Steven Gore, Leo F. VerdonckNasheed M. Hossain, Natasha Kekre, Bipin Savani, Michael Byrne, Christopher Kanakry, Mitchell S. Cairo, Stefan Ciurea, Harry C. Schouten, Christopher Bredeson, Reinhold Munker, Hillard Lazarus, Jean Yves Cahn, Marjolein van Der Poel, David Rizzieri, Jean A. Yared, Cesar Freytes, Jan Cerny, Mahmoud Aljurf, Neil D. Palmisiano, Attaphol Pawarode, Vera Ulrike Bacher, Michael R. Grunwald, Sunita Nathan, Baldeep Wirk, Gerhard C. Hildebrandt, Sachiko Seo, Richard F. Olsson, Biju George, Marcos de Lima, Christopher S. Hourigan, Brenda M. Sandmaier, Mark Litzow, Partow Kebriaei, Wael Saber, Daniel Weisdorf

Resultado de la investigación: Article › revisión exhaustiva

7 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study'. En conjunto forman una huella única.

Medicine and Dentistry